Peng Zhou
Chief Tech/Sci/R&D Officer chez Rheonix, Inc.
Profil
Dr. Peng Zhou joined Ampersand as an Operating Partner in 2018 and has served as an Executive Advisor since 2022.
He currently serves as President of Asia Operations for prior Ampersand portfolio company Adaptas Solutions, which was sold to IMI plc, and is the President & CEO of Yixin Diagnostic Technology, Inc. located in Suzhou, China.
Previously, Peng served as a member of the Board of Directors and Vice President of R&D for Bohui Innovation Technology and held senior positions with Rheonix, Kionix and Bristol-Myers Squibb.
Peng holds a B.S.
in Chemistry from Jilin University and a Ph.D.
in Chemistry from Columbia University.
Postes actifs de Peng Zhou
| Sociétés | Poste | Début |
|---|---|---|
Rheonix, Inc.
 Rheonix, Inc. Medical SpecialtiesHealth Technology Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY. | Chief Tech/Sci/R&D Officer | 10/11/2009 |
| Beijing Boang Kionix Microfluidics Technology Co. Ltd. | Director/Board Member | - |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Consultant / Advisor | - |
Anciens postes connus de Peng Zhou
| Sociétés | Poste | Fin |
|---|---|---|
| BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD. | Director/Board Member | 15/05/2020 |
| Arris Pharmaceuticals Corp. | Corporate Officer/Principal | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | - |
Kionix, Inc.
 Kionix, Inc. Electronic Production EquipmentElectronic Technology Kionix, Inc. engages in the manufacture of inertial sensor. Its products include accelerometers, gyroscopes, 6-axis and 9-axis solutions, and sensor fusion. The company was founded in 1993 and is headquartered in Ithaca, NY. | Corporate Officer/Principal | - |
Formation de Peng Zhou
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Jilin University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Kionix, Inc.
Kionix, Inc. Electronic Production EquipmentElectronic Technology Kionix, Inc. engages in the manufacture of inertial sensor. Its products include accelerometers, gyroscopes, 6-axis and 9-axis solutions, and sensor fusion. The company was founded in 1993 and is headquartered in Ithaca, NY. | Electronic Technology |
Rheonix, Inc.
Rheonix, Inc. Medical SpecialtiesHealth Technology Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY. | Health Technology |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management LLC (Ampersand Management) is a private equity firm founded in 1988 by Richard A. Charpie. The firm is headquartered in Wellesley, Massachusetts. | Finance |
| Arris Pharmaceuticals Corp. | |
| Beijing Boang Kionix Microfluidics Technology Co. Ltd. |
